Catalyst Brief

← Calendar

Readoutin 14d

Ausper Biopharma Co., Ltd. — AHB-137

Phase 3 primary completion: Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE).

Date
Dec 2026
Type
Readout
Indication
Chronic Hepatitis B

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.